Home>Topics>Stocks>Pharmaceutical Product Development

Pharmaceutical Product Development PPDI

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. New Morningstar Analyst Report for Icon PLC

      Stock Reports

      Mon, 21 Oct 2013

      competes with several larger and more established rivals in the CRO industry, such as Covance and Pharmaceutical Product Development , which boast greater capital resources and staffing capabilities.We expect the cost advantages

    2. Diamond Hill Small-Mid Cap Fund Fourth Quarter Commentary

      Headlines

      Wed, 1 Feb 2012

      and development services provider Pharmaceutical Product Development , Inc. was taken private during ..... During the quarter, our position in Pharmaceutical Product Development , Inc. was eliminated as two private

    3. Diamond Hill Long-Short Fund Fourth Quarter Commentary

      Headlines

      Wed, 1 Feb 2012

      saturation. Eliminated Positions We eliminated our long positions in Pharmaceutical Product Development , Inc. and KLA-Tencor Corp. Pharmaceutical Product Development was acquired by two private equity firms while KLA-Tencor was eliminated

    4. Diamond Hill Research Opportunities Fund Fourth Quarter Commentary

      Headlines

      Wed, 1 Feb 2012

      Advent Software, Inc. Eliminated Positions We eliminated our long positions in Assurant, Inc. , Pharmaceutical Product Development , Inc. , Bristol-Myers Squibb Co. , Wal-Mart Stores, Inc. , National Penn Bancshares, Inc

    5. Wall Street Breakfast: Must-Know News

      Headlines

      Tue, 15 Nov 2011

      SPLS]], [[TJX]], [[WMT]] Notable earnings after Tuesday's close: [[A]], [[ADSK]], [[DELL]], [[ PPDI ]] Get Wall Street Breakfast by email -- it's free and takes only seconds to sign up. Complete Story »

    6. LPC-PPD to launch $1.325 bln buyout loan to retail syndication

      Headlines

      Fri, 4 Nov 2011

      NEW YORK, Nov 4 (LPC) - Pharmaceutical Product Development (PPD) is launching on November 8 at 10 a.m. the retail syndication of its buyout loan, sources said.

    7. New Morningstar Analyst Report - Pharmaceutical Product Development , Inc.

      Stock Reports

      Mon, 3 Oct 2011

      barrier to change for the company. Pharmaceutical Product Development is a global contract research organization ..... While economic uncertainty has sent Pharmaceutical Product Development 's cancellation rate soaring

    8. PPD to Become a Private Company; Deal Value Close to our Fair Value Estimate

      Commentary

      Mon, 3 Oct 2011

      Pharmaceutical Product Development PPDI announced today that it will be acquired by private equity groups The Carlyle Group and Hellman & Friedman for $3.9 billion

    9. PPD appoints new CEO

      Headlines

      Mon, 19 Sep 2011

      (Reuters) - Pharmaceutical Product Development Inc said it has appointed Raymond Hill as chief executive officer, effective September 16, four months after David Grange retired as CEO.

    10. PPD Names New CEO

      Commentary

      Mon, 19 Sep 2011

      Pharmaceutical Product Development PPDI announced that it had hired an outsider as its key leader. Raymond H. Hill joined PPD as chief executive officer and a member

    « Prev12345Next »
    Content Partners